 Monika Fleshner
Concepts (699)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress, Psychological | 59 | 2017 | 1119 | 7.230 |
Why?
| | Stress, Physiological | 47 | 2019 | 450 | 7.000 |
Why?
| | Prebiotics | 8 | 2025 | 27 | 4.750 |
Why?
| | Physical Conditioning, Animal | 22 | 2019 | 254 | 4.150 |
Why?
| | Rats, Inbred F344 | 48 | 2019 | 267 | 3.350 |
Why?
| | Rats | 137 | 2024 | 5594 | 3.330 |
Why?
| | Motor Activity | 28 | 2019 | 710 | 3.230 |
Why?
| | HSP72 Heat-Shock Proteins | 17 | 2014 | 32 | 3.090 |
Why?
| | Helplessness, Learned | 13 | 2016 | 68 | 2.890 |
Why?
| | Corticosterone | 38 | 2016 | 242 | 2.190 |
Why?
| | Running | 14 | 2016 | 230 | 2.130 |
Why?
| | Brain | 27 | 2024 | 2792 | 1.990 |
Why?
| | Rats, Sprague-Dawley | 71 | 2024 | 2499 | 1.890 |
Why?
| | Glucans | 2 | 2025 | 27 | 1.790 |
Why?
| | Oligosaccharides | 2 | 2025 | 57 | 1.750 |
Why?
| | Animals | 164 | 2025 | 37217 | 1.750 |
Why?
| | Heat-Shock Proteins | 10 | 2024 | 142 | 1.720 |
Why?
| | Gastrointestinal Microbiome | 5 | 2025 | 696 | 1.570 |
Why?
| | Cytokines | 17 | 2024 | 2080 | 1.440 |
Why?
| | Electroshock | 28 | 2015 | 143 | 1.440 |
Why?
| | Fear | 17 | 2015 | 344 | 1.420 |
Why?
| | Immune System | 9 | 2017 | 181 | 1.410 |
Why?
| | Escherichia coli Infections | 9 | 2012 | 115 | 1.350 |
Why?
| | Exosomes | 5 | 2017 | 105 | 1.340 |
Why?
| | Circadian Rhythm | 7 | 2021 | 489 | 1.300 |
Why?
| | Hemocyanins | 19 | 2008 | 61 | 1.250 |
Why?
| | Interleukin-1beta | 6 | 2016 | 378 | 1.250 |
Why?
| | Inflammation | 12 | 2024 | 2850 | 1.180 |
Why?
| | Bacteria | 7 | 2024 | 867 | 1.150 |
Why?
| | Inflammasomes | 3 | 2016 | 133 | 1.140 |
Why?
| | Exercise | 17 | 2024 | 2072 | 1.140 |
Why?
| | Immunity, Innate | 9 | 2014 | 824 | 1.130 |
Why?
| | Proto-Oncogene Proteins c-fos | 11 | 2019 | 191 | 1.120 |
Why?
| | Physical Exertion | 6 | 2012 | 209 | 1.110 |
Why?
| | Corpus Striatum | 7 | 2017 | 176 | 1.100 |
Why?
| | Gastrointestinal Tract | 3 | 2016 | 204 | 1.090 |
Why?
| | Spleen | 13 | 2013 | 523 | 1.070 |
Why?
| | Lactoferrin | 2 | 2018 | 40 | 1.070 |
Why?
| | Anxiety | 10 | 2018 | 1072 | 1.060 |
Why?
| | Male | 145 | 2024 | 68260 | 1.020 |
Why?
| | Immunoglobulin M | 11 | 2008 | 287 | 1.010 |
Why?
| | Feces | 4 | 2025 | 486 | 0.990 |
Why?
| | Serotonin | 10 | 2019 | 322 | 0.990 |
Why?
| | Diet | 5 | 2024 | 1269 | 0.970 |
Why?
| | Neuronal Plasticity | 12 | 2018 | 302 | 0.960 |
Why?
| | Hypergravity | 1 | 2025 | 6 | 0.940 |
Why?
| | Interleukin-1 | 15 | 2008 | 966 | 0.930 |
Why?
| | Antibody Formation | 10 | 2008 | 298 | 0.920 |
Why?
| | Amygdala | 7 | 2017 | 191 | 0.910 |
Why?
| | Sympathetic Nervous System | 4 | 2014 | 172 | 0.890 |
Why?
| | MicroRNAs | 3 | 2017 | 675 | 0.880 |
Why?
| | Receptors, Adrenergic, alpha-1 | 7 | 2014 | 45 | 0.850 |
Why?
| | Bile Acids and Salts | 2 | 2024 | 151 | 0.840 |
Why?
| | Lipopolysaccharides | 11 | 2024 | 888 | 0.830 |
Why?
| | Raphe Nuclei | 7 | 2019 | 109 | 0.800 |
Why?
| | Behavior, Animal | 13 | 2019 | 512 | 0.790 |
Why?
| | Hippocampus | 18 | 2017 | 929 | 0.770 |
Why?
| | RNA, Ribosomal, 16S | 5 | 2025 | 553 | 0.750 |
Why?
| | Conditioning, Classical | 7 | 2015 | 107 | 0.730 |
Why?
| | Adipose Tissue | 3 | 2016 | 643 | 0.720 |
Why?
| | Glycolipids | 2 | 2019 | 42 | 0.700 |
Why?
| | Neuroendocrine Cells | 1 | 2020 | 33 | 0.670 |
Why?
| | Stress Disorders, Post-Traumatic | 8 | 2021 | 850 | 0.670 |
Why?
| | Catecholamines | 7 | 2014 | 91 | 0.670 |
Why?
| | Immunoglobulin G | 13 | 2008 | 898 | 0.660 |
Why?
| | Conditioning, Operant | 5 | 2012 | 102 | 0.650 |
Why?
| | Microbiota | 2 | 2019 | 758 | 0.630 |
Why?
| | Dopamine | 3 | 2015 | 308 | 0.630 |
Why?
| | Receptor, Serotonin, 5-HT2C | 4 | 2012 | 14 | 0.630 |
Why?
| | Gene Expression Regulation | 8 | 2014 | 2590 | 0.620 |
Why?
| | Glycoproteins | 2 | 2019 | 354 | 0.610 |
Why?
| | Tumor Necrosis Factor-alpha | 7 | 2016 | 1244 | 0.600 |
Why?
| | Body Weight | 15 | 2016 | 992 | 0.590 |
Why?
| | Prefrontal Cortex | 5 | 2017 | 306 | 0.580 |
Why?
| | Mentors | 1 | 2021 | 209 | 0.580 |
Why?
| | Brain-Derived Neurotrophic Factor | 5 | 2018 | 140 | 0.580 |
Why?
| | Interleukin-10 | 7 | 2016 | 304 | 0.570 |
Why?
| | Microglia | 2 | 2021 | 255 | 0.570 |
Why?
| | Sleep | 4 | 2021 | 799 | 0.560 |
Why?
| | Fatigue | 3 | 2012 | 336 | 0.540 |
Why?
| | Alarmins | 1 | 2017 | 27 | 0.540 |
Why?
| | Signal Transduction | 10 | 2023 | 5086 | 0.530 |
Why?
| | Food Deprivation | 1 | 2016 | 27 | 0.510 |
Why?
| | Vagus Nerve | 7 | 2000 | 88 | 0.510 |
Why?
| | Escape Reaction | 6 | 2012 | 58 | 0.510 |
Why?
| | Inflammation Mediators | 4 | 2013 | 513 | 0.510 |
Why?
| | Analysis of Variance | 15 | 2015 | 1317 | 0.490 |
Why?
| | Sleep, REM | 1 | 2016 | 34 | 0.490 |
Why?
| | Central Nervous System | 2 | 2016 | 263 | 0.480 |
Why?
| | Butyrates | 1 | 2016 | 60 | 0.480 |
Why?
| | Receptors, Glucocorticoid | 4 | 2013 | 137 | 0.480 |
Why?
| | Emotions | 3 | 2018 | 568 | 0.480 |
Why?
| | RNA, Messenger | 12 | 2018 | 2815 | 0.470 |
Why?
| | Association Learning | 3 | 2010 | 63 | 0.470 |
Why?
| | Neuroimmunomodulation | 8 | 2003 | 66 | 0.470 |
Why?
| | Mood Disorders | 1 | 2016 | 136 | 0.460 |
Why?
| | Macrophages, Peritoneal | 2 | 2014 | 95 | 0.460 |
Why?
| | Norepinephrine | 6 | 2006 | 192 | 0.450 |
Why?
| | Chemokines | 2 | 2012 | 226 | 0.440 |
Why?
| | Interleukin-6 | 7 | 2016 | 785 | 0.440 |
Why?
| | Interleukin-18 | 2 | 2012 | 236 | 0.440 |
Why?
| | T-Lymphocytes | 3 | 2012 | 1986 | 0.440 |
Why?
| | Serum | 1 | 2014 | 60 | 0.430 |
Why?
| | Extracellular Space | 3 | 2005 | 129 | 0.430 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2016 | 201 | 0.420 |
Why?
| | Time Factors | 25 | 2016 | 6851 | 0.420 |
Why?
| | Sleep Deprivation | 4 | 2020 | 181 | 0.420 |
Why?
| | Receptors, Adrenergic | 1 | 2013 | 21 | 0.420 |
Why?
| | Adaptation, Physiological | 6 | 2007 | 548 | 0.420 |
Why?
| | Arousal | 9 | 2021 | 157 | 0.420 |
Why?
| | Adipose Tissue, White | 1 | 2013 | 43 | 0.410 |
Why?
| | Receptor, Serotonin, 5-HT1A | 3 | 2016 | 36 | 0.410 |
Why?
| | Reward | 3 | 2016 | 251 | 0.400 |
Why?
| | Chemokine CCL2 | 4 | 2014 | 116 | 0.400 |
Why?
| | Glucocorticoids | 5 | 2012 | 528 | 0.390 |
Why?
| | Psychoneuroimmunology | 3 | 2005 | 10 | 0.390 |
Why?
| | Transcortin | 6 | 2007 | 15 | 0.390 |
Why?
| | Intestines | 1 | 2015 | 356 | 0.380 |
Why?
| | Immune Tolerance | 3 | 2005 | 366 | 0.380 |
Why?
| | Respiratory Tract Infections | 2 | 2016 | 383 | 0.380 |
Why?
| | Injections, Intraperitoneal | 11 | 2008 | 114 | 0.370 |
Why?
| | Antigens | 4 | 2003 | 356 | 0.370 |
Why?
| | Obesity, Abdominal | 1 | 2012 | 44 | 0.370 |
Why?
| | Aminopyridines | 3 | 2009 | 102 | 0.370 |
Why?
| | Nitric Oxide | 6 | 2014 | 893 | 0.360 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2016 | 357 | 0.350 |
Why?
| | Myeloid Cells | 1 | 2012 | 151 | 0.350 |
Why?
| | Mental Health | 2 | 2015 | 738 | 0.340 |
Why?
| | Body Temperature | 5 | 2014 | 224 | 0.340 |
Why?
| | Mifepristone | 3 | 2001 | 63 | 0.330 |
Why?
| | Memory | 9 | 2015 | 258 | 0.330 |
Why?
| | Limbic System | 1 | 2010 | 52 | 0.330 |
Why?
| | Freezing Reaction, Cataleptic | 4 | 2012 | 22 | 0.330 |
Why?
| | Neurons | 8 | 2017 | 1601 | 0.330 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 8 | 2014 | 849 | 0.330 |
Why?
| | Metagenome | 1 | 2010 | 149 | 0.320 |
Why?
| | Volition | 1 | 2009 | 34 | 0.310 |
Why?
| | Disease Models, Animal | 13 | 2016 | 4315 | 0.310 |
Why?
| | Depression | 3 | 2012 | 1466 | 0.310 |
Why?
| | Random Allocation | 3 | 2016 | 363 | 0.310 |
Why?
| | Extracellular Fluid | 3 | 2006 | 35 | 0.310 |
Why?
| | Brain Chemistry | 3 | 2005 | 117 | 0.310 |
Why?
| | Space Flight | 2 | 2000 | 88 | 0.310 |
Why?
| | Indoles | 3 | 2009 | 414 | 0.300 |
Why?
| | Locomotion | 2 | 2012 | 104 | 0.300 |
Why?
| | Serotonin 5-HT2 Receptor Antagonists | 1 | 2008 | 10 | 0.300 |
Why?
| | Electric Stimulation | 9 | 2013 | 276 | 0.300 |
Why?
| | Lipid Droplets | 2 | 2019 | 23 | 0.300 |
Why?
| | Exercise Therapy | 3 | 2008 | 439 | 0.300 |
Why?
| | Up-Regulation | 4 | 2012 | 851 | 0.290 |
Why?
| | Predatory Behavior | 5 | 2011 | 49 | 0.290 |
Why?
| | Exercise Test | 3 | 2007 | 622 | 0.290 |
Why?
| | Fluvoxamine | 1 | 2008 | 17 | 0.290 |
Why?
| | Antibodies | 3 | 2005 | 404 | 0.280 |
Why?
| | Homeostasis | 3 | 2017 | 614 | 0.280 |
Why?
| | B-Lymphocytes | 2 | 2003 | 855 | 0.280 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2008 | 69 | 0.270 |
Why?
| | Heat-Shock Response | 2 | 2024 | 75 | 0.270 |
Why?
| | Adrenal Glands | 8 | 2008 | 75 | 0.270 |
Why?
| | Mycobacterium | 2 | 2021 | 110 | 0.270 |
Why?
| | Adrenalectomy | 11 | 2005 | 65 | 0.270 |
Why?
| | Humans | 46 | 2024 | 138651 | 0.270 |
Why?
| | Pituitary-Adrenal System | 4 | 2012 | 170 | 0.260 |
Why?
| | Extinction, Psychological | 3 | 2015 | 88 | 0.260 |
Why?
| | Receptors, Catecholamine | 1 | 2006 | 4 | 0.260 |
Why?
| | Hypothalamo-Hypophyseal System | 4 | 2012 | 205 | 0.260 |
Why?
| | Physical Fitness | 2 | 2006 | 206 | 0.250 |
Why?
| | Receptors, Dopamine D2 | 3 | 2014 | 96 | 0.250 |
Why?
| | Heart Rate | 6 | 2016 | 802 | 0.250 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 2005 | 21 | 0.240 |
Why?
| | Adjuvants, Immunologic | 4 | 2003 | 237 | 0.240 |
Why?
| | Spike Glycoprotein, Coronavirus | 2 | 2024 | 119 | 0.240 |
Why?
| | Membrane Glycoproteins | 2 | 2005 | 499 | 0.240 |
Why?
| | Galactose | 1 | 2025 | 33 | 0.230 |
Why?
| | Neural Pathways | 4 | 2015 | 303 | 0.230 |
Why?
| | Cognition | 6 | 2024 | 1179 | 0.230 |
Why?
| | Vagotomy | 8 | 2000 | 34 | 0.230 |
Why?
| | Receptor, Serotonin, 5-HT1B | 1 | 2005 | 6 | 0.230 |
Why?
| | In Situ Hybridization | 4 | 2012 | 319 | 0.230 |
Why?
| | Physical Endurance | 1 | 2006 | 273 | 0.230 |
Why?
| | Immunomodulation | 2 | 2017 | 99 | 0.220 |
Why?
| | Adrenocorticotropic Hormone | 7 | 2013 | 148 | 0.220 |
Why?
| | Sick Role | 1 | 2004 | 19 | 0.220 |
Why?
| | Dose-Response Relationship, Drug | 10 | 2013 | 2049 | 0.220 |
Why?
| | Persian Gulf Syndrome | 1 | 2024 | 17 | 0.220 |
Why?
| | Psychomotor Performance | 3 | 2019 | 317 | 0.220 |
Why?
| | Memory Disorders | 3 | 2013 | 178 | 0.220 |
Why?
| | Physiology | 1 | 2024 | 14 | 0.210 |
Why?
| | Immunization | 6 | 2021 | 405 | 0.210 |
Why?
| | Long-Term Potentiation | 7 | 1999 | 199 | 0.210 |
Why?
| | Membrane Transport Proteins | 1 | 2005 | 152 | 0.210 |
Why?
| | Encephalitis | 1 | 2005 | 136 | 0.210 |
Why?
| | Morphine | 5 | 2011 | 171 | 0.200 |
Why?
| | CD5 Antigens | 1 | 2003 | 9 | 0.200 |
Why?
| | Social Behavior | 4 | 2016 | 292 | 0.200 |
Why?
| | Hypothalamus | 4 | 2017 | 153 | 0.200 |
Why?
| | CD11 Antigens | 1 | 2003 | 31 | 0.200 |
Why?
| | Propranolol | 3 | 2008 | 45 | 0.200 |
Why?
| | Genes, fos | 1 | 2003 | 37 | 0.200 |
Why?
| | Lung | 1 | 2016 | 4106 | 0.200 |
Why?
| | Muscle Strength | 1 | 2006 | 320 | 0.190 |
Why?
| | Myocardium | 4 | 2007 | 921 | 0.190 |
Why?
| | Protein Biosynthesis | 1 | 2005 | 434 | 0.190 |
Why?
| | Microdialysis | 4 | 2015 | 54 | 0.190 |
Why?
| | B-Lymphocyte Subsets | 1 | 2002 | 77 | 0.190 |
Why?
| | Lymph Nodes | 5 | 2006 | 492 | 0.180 |
Why?
| | Medicine | 1 | 2024 | 125 | 0.180 |
Why?
| | Cross-Over Studies | 1 | 2024 | 556 | 0.180 |
Why?
| | Depressive Disorder | 3 | 2012 | 391 | 0.180 |
Why?
| | Maze Learning | 6 | 2015 | 103 | 0.180 |
Why?
| | Dehydroepiandrosterone | 3 | 1997 | 51 | 0.180 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2000 | 1098 | 0.180 |
Why?
| | Dehydroepiandrosterone Sulfate | 3 | 1999 | 43 | 0.180 |
Why?
| | T-Lymphocyte Subsets | 2 | 1995 | 415 | 0.180 |
Why?
| | Bacteroidetes | 1 | 2021 | 24 | 0.180 |
Why?
| | Interferon-gamma | 4 | 2001 | 786 | 0.180 |
Why?
| | Sex Characteristics | 2 | 2006 | 770 | 0.180 |
Why?
| | Adrenergic beta-Antagonists | 3 | 2008 | 228 | 0.180 |
Why?
| | Tyrosine 3-Monooxygenase | 3 | 2016 | 73 | 0.170 |
Why?
| | Gene Expression | 2 | 2018 | 1488 | 0.170 |
Why?
| | Weightlessness Simulation | 1 | 2000 | 7 | 0.170 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 600 | 0.170 |
Why?
| | Pituitary Gland | 5 | 2006 | 150 | 0.170 |
Why?
| | Weightlessness | 1 | 2000 | 46 | 0.170 |
Why?
| | Acoustic Stimulation | 7 | 2015 | 319 | 0.170 |
Why?
| | Antidepressive Agents, Tricyclic | 2 | 2013 | 30 | 0.160 |
Why?
| | Neurosecretory Systems | 1 | 2000 | 31 | 0.160 |
Why?
| | Radiation Effects | 1 | 1999 | 7 | 0.160 |
Why?
| | Astronauts | 1 | 1999 | 27 | 0.160 |
Why?
| | Mental Recall | 4 | 1997 | 207 | 0.160 |
Why?
| | Dentate Gyrus | 2 | 2010 | 39 | 0.160 |
Why?
| | Exploratory Behavior | 3 | 2015 | 91 | 0.160 |
Why?
| | Avoidance Learning | 2 | 2013 | 74 | 0.160 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5798 | 0.160 |
Why?
| | Fever | 3 | 2011 | 305 | 0.160 |
Why?
| | Blood Proteins | 2 | 2002 | 244 | 0.150 |
Why?
| | Serotonergic Neurons | 1 | 2019 | 29 | 0.150 |
Why?
| | Tryptophan Hydroxylase | 1 | 2019 | 53 | 0.150 |
Why?
| | Citrate (si)-Synthase | 4 | 2007 | 60 | 0.150 |
Why?
| | Chromatography, Liquid | 1 | 2021 | 448 | 0.150 |
Why?
| | Adrenal Cortex Hormones | 4 | 2024 | 496 | 0.150 |
Why?
| | Prazosin | 2 | 2011 | 25 | 0.150 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 51 | 0.150 |
Why?
| | RNA, Bacterial | 1 | 2020 | 188 | 0.150 |
Why?
| | Serotonin 5-HT2 Receptor Agonists | 2 | 2008 | 6 | 0.150 |
Why?
| | Mice | 8 | 2025 | 17814 | 0.150 |
Why?
| | Cells, Cultured | 5 | 2014 | 4181 | 0.140 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 555 | 0.140 |
Why?
| | Cats | 5 | 2015 | 224 | 0.140 |
Why?
| | Toll-Like Receptors | 2 | 2011 | 189 | 0.140 |
Why?
| | Dexamethasone | 3 | 2001 | 375 | 0.140 |
Why?
| | Biomedical Research | 1 | 2024 | 694 | 0.140 |
Why?
| | Peptides | 2 | 2013 | 976 | 0.130 |
Why?
| | Analgesics, Opioid | 3 | 2012 | 1089 | 0.130 |
Why?
| | Lymphocytes | 4 | 2011 | 395 | 0.130 |
Why?
| | Female | 22 | 2025 | 73763 | 0.130 |
Why?
| | Exercise Movement Techniques | 1 | 2016 | 7 | 0.130 |
Why?
| | Behavior | 2 | 2006 | 92 | 0.120 |
Why?
| | Leukocyte Count | 3 | 2002 | 326 | 0.120 |
Why?
| | Immunoglobulins | 1 | 1996 | 168 | 0.120 |
Why?
| | Immunosuppressive Agents | 1 | 2001 | 849 | 0.120 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2016 | 158 | 0.120 |
Why?
| | Aging | 3 | 2004 | 1855 | 0.120 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 67 | 0.120 |
Why?
| | Bacterial Vaccines | 1 | 2016 | 63 | 0.120 |
Why?
| | Dysgammaglobulinemia | 1 | 1995 | 2 | 0.120 |
Why?
| | IgG Deficiency | 1 | 1995 | 7 | 0.120 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2016 | 131 | 0.120 |
Why?
| | Tertiary Care Centers | 1 | 2016 | 168 | 0.110 |
Why?
| | Leukocyte Common Antigens | 1 | 1995 | 90 | 0.110 |
Why?
| | Muscle, Skeletal | 5 | 2007 | 1729 | 0.110 |
Why?
| | Immunity | 3 | 2002 | 140 | 0.110 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 1995 | 51 | 0.110 |
Why?
| | Leptin | 1 | 2016 | 242 | 0.110 |
Why?
| | Host-Pathogen Interactions | 2 | 2015 | 368 | 0.110 |
Why?
| | Symbiosis | 1 | 2015 | 81 | 0.110 |
Why?
| | CD4 Antigens | 1 | 1995 | 141 | 0.110 |
Why?
| | Enkephalins | 1 | 2014 | 20 | 0.110 |
Why?
| | Dynorphins | 1 | 2014 | 9 | 0.110 |
Why?
| | Neuralgia | 1 | 2016 | 139 | 0.110 |
Why?
| | Tyrosine | 2 | 2005 | 227 | 0.110 |
Why?
| | Receptor, Adenosine A1 | 1 | 2014 | 10 | 0.110 |
Why?
| | Metabolomics | 1 | 2020 | 689 | 0.110 |
Why?
| | Receptor, Adenosine A2A | 1 | 2014 | 22 | 0.110 |
Why?
| | Hydrocortisone | 3 | 2015 | 314 | 0.110 |
Why?
| | Nitrites | 3 | 2016 | 89 | 0.110 |
Why?
| | Culture Media | 1 | 2014 | 163 | 0.110 |
Why?
| | Peritoneum | 3 | 2003 | 43 | 0.110 |
Why?
| | Receptors, Dopamine D1 | 1 | 2014 | 34 | 0.110 |
Why?
| | Tail | 4 | 1998 | 28 | 0.110 |
Why?
| | Convulsants | 1 | 1993 | 8 | 0.110 |
Why?
| | Primary Cell Culture | 1 | 2014 | 171 | 0.110 |
Why?
| | Anxiety Disorders | 2 | 2008 | 377 | 0.110 |
Why?
| | Adrenergic alpha-Antagonists | 2 | 2005 | 34 | 0.100 |
Why?
| | Carbolines | 1 | 1993 | 32 | 0.100 |
Why?
| | Acute-Phase Reaction | 2 | 2007 | 39 | 0.100 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2017 | 415 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 896 | 0.100 |
Why?
| | Immunity, Cellular | 3 | 2005 | 269 | 0.100 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2013 | 46 | 0.100 |
Why?
| | Hyperalgesia | 3 | 2016 | 127 | 0.100 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2013 | 74 | 0.100 |
Why?
| | Bradykinin | 1 | 2013 | 46 | 0.100 |
Why?
| | History, 21st Century | 2 | 2024 | 214 | 0.100 |
Why?
| | Molecular Probes | 1 | 2013 | 34 | 0.100 |
Why?
| | Colitis | 1 | 2016 | 266 | 0.100 |
Why?
| | Amnesia | 2 | 2011 | 46 | 0.100 |
Why?
| | Telemetry | 1 | 2013 | 40 | 0.100 |
Why?
| | History, 20th Century | 2 | 2024 | 323 | 0.100 |
Why?
| | Diaphragm | 3 | 1998 | 43 | 0.100 |
Why?
| | Macrophage Inflammatory Proteins | 1 | 2012 | 11 | 0.100 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1229 | 0.100 |
Why?
| | Reaction Time | 3 | 2012 | 421 | 0.100 |
Why?
| | Cues | 3 | 2015 | 319 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2012 | 1145 | 0.100 |
Why?
| | Synaptotagmin I | 1 | 2012 | 15 | 0.100 |
Why?
| | Phenylephrine | 2 | 2001 | 75 | 0.090 |
Why?
| | Thymus Gland | 3 | 2008 | 314 | 0.090 |
Why?
| | Caspase Inhibitors | 1 | 2012 | 81 | 0.090 |
Why?
| | Veterans | 1 | 2024 | 1486 | 0.090 |
Why?
| | Body Fat Distribution | 1 | 2012 | 48 | 0.090 |
Why?
| | Lipid Bilayers | 1 | 2013 | 103 | 0.090 |
Why?
| | Life Style | 2 | 2005 | 478 | 0.090 |
Why?
| | Fetal Blood | 1 | 2014 | 336 | 0.090 |
Why?
| | Area Under Curve | 1 | 2013 | 319 | 0.090 |
Why?
| | Rats, Nude | 1 | 2012 | 23 | 0.090 |
Why?
| | Injections, Subcutaneous | 2 | 2003 | 162 | 0.090 |
Why?
| | Pulmonary Fibrosis | 1 | 2016 | 399 | 0.090 |
Why?
| | Gliosarcoma | 1 | 1992 | 8 | 0.090 |
Why?
| | Caspase 1 | 1 | 2012 | 146 | 0.090 |
Why?
| | Thiazepines | 2 | 2013 | 6 | 0.090 |
Why?
| | Mental Disorders | 1 | 2020 | 1096 | 0.090 |
Why?
| | Lymphocyte Transfusion | 1 | 1992 | 21 | 0.090 |
Why?
| | Cattle | 1 | 2014 | 991 | 0.090 |
Why?
| | Cell Communication | 1 | 2014 | 316 | 0.090 |
Why?
| | Lymphocyte Count | 2 | 2003 | 166 | 0.090 |
Why?
| | Saimiri | 1 | 2011 | 9 | 0.090 |
Why?
| | Macrophages | 2 | 2000 | 1543 | 0.090 |
Why?
| | Neurobiology | 1 | 2011 | 14 | 0.090 |
Why?
| | Locus Coeruleus | 1 | 2011 | 22 | 0.090 |
Why?
| | Uric Acid | 1 | 2012 | 165 | 0.090 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2011 | 47 | 0.090 |
Why?
| | Cell Survival | 1 | 2014 | 1123 | 0.090 |
Why?
| | Body Composition | 1 | 2015 | 694 | 0.090 |
Why?
| | Aged | 5 | 2008 | 24024 | 0.090 |
Why?
| | Laparotomy | 1 | 2011 | 112 | 0.090 |
Why?
| | Receptors, Opioid, delta | 1 | 2010 | 10 | 0.090 |
Why?
| | Biosensing Techniques | 1 | 2012 | 133 | 0.090 |
Why?
| | Endocrine Glands | 1 | 1990 | 16 | 0.080 |
Why?
| | Peptides, Cyclic | 1 | 2012 | 265 | 0.080 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2011 | 346 | 0.080 |
Why?
| | C-Reactive Protein | 3 | 2024 | 415 | 0.080 |
Why?
| | DNA Primers | 1 | 2011 | 508 | 0.080 |
Why?
| | Epinephrine | 3 | 2004 | 145 | 0.080 |
Why?
| | Liver | 4 | 2006 | 1805 | 0.080 |
Why?
| | Interleukin-2 | 1 | 1992 | 451 | 0.080 |
Why?
| | Rats, Inbred Strains | 6 | 1995 | 345 | 0.080 |
Why?
| | Microinjections | 2 | 2008 | 86 | 0.080 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 275 | 0.080 |
Why?
| | Pain | 4 | 2011 | 777 | 0.080 |
Why?
| | Cell Count | 2 | 2002 | 325 | 0.080 |
Why?
| | Stress Disorders, Traumatic | 1 | 2009 | 23 | 0.080 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1731 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 462 | 0.080 |
Why?
| | Glucose | 1 | 2014 | 1032 | 0.080 |
Why?
| | CA1 Region, Hippocampal | 1 | 2009 | 52 | 0.080 |
Why?
| | Immunologic Deficiency Syndromes | 3 | 2001 | 72 | 0.070 |
Why?
| | Naltrexone | 4 | 1994 | 102 | 0.070 |
Why?
| | Reference Values | 5 | 2007 | 799 | 0.070 |
Why?
| | Antihypertensive Agents | 1 | 2013 | 505 | 0.070 |
Why?
| | Neutrophils | 3 | 2011 | 1274 | 0.070 |
Why?
| | Nadolol | 1 | 2008 | 4 | 0.070 |
Why?
| | Analgesics | 1 | 1990 | 225 | 0.070 |
Why?
| | Insulin | 2 | 2016 | 2448 | 0.070 |
Why?
| | Habituation, Psychophysiologic | 1 | 2008 | 57 | 0.070 |
Why?
| | Escherichia coli | 2 | 2002 | 827 | 0.070 |
Why?
| | Lipids | 1 | 2012 | 675 | 0.070 |
Why?
| | Immunotherapy, Adoptive | 1 | 1992 | 349 | 0.070 |
Why?
| | Isoproterenol | 1 | 2008 | 101 | 0.070 |
Why?
| | Pyrazines | 1 | 2008 | 87 | 0.070 |
Why?
| | Injections, Intraventricular | 4 | 1998 | 55 | 0.070 |
Why?
| | Flow Cytometry | 2 | 2003 | 1192 | 0.070 |
Why?
| | Reinforcement Schedule | 1 | 2007 | 31 | 0.070 |
Why?
| | Adrenergic beta-Agonists | 1 | 2008 | 97 | 0.070 |
Why?
| | Substantia Nigra | 1 | 2008 | 58 | 0.070 |
Why?
| | Nerve Net | 1 | 2010 | 268 | 0.070 |
Why?
| | Weight Loss | 1 | 1993 | 783 | 0.070 |
Why?
| | Aggression | 1 | 1989 | 199 | 0.070 |
Why?
| | Mesentery | 2 | 1998 | 44 | 0.060 |
Why?
| | Biogenic Monoamines | 1 | 2006 | 16 | 0.060 |
Why?
| | Computational Biology | 1 | 2011 | 649 | 0.060 |
Why?
| | Blood Glucose | 1 | 2016 | 2239 | 0.060 |
Why?
| | Recombinant Proteins | 5 | 2000 | 1352 | 0.060 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2006 | 50 | 0.060 |
Why?
| | Fluoxetine | 1 | 2006 | 55 | 0.060 |
Why?
| | Estrous Cycle | 1 | 2006 | 20 | 0.060 |
Why?
| | Piperazines | 1 | 2008 | 345 | 0.060 |
Why?
| | Cell Adhesion Molecules | 1 | 2007 | 178 | 0.060 |
Why?
| | Adaptation, Psychological | 1 | 2011 | 673 | 0.060 |
Why?
| | Pulmonary Edema | 1 | 2006 | 114 | 0.060 |
Why?
| | Labetalol | 1 | 2005 | 6 | 0.060 |
Why?
| | Methyltyrosines | 1 | 2005 | 3 | 0.060 |
Why?
| | Mianserin | 1 | 2005 | 5 | 0.060 |
Why?
| | Hypophysectomy | 1 | 2005 | 15 | 0.060 |
Why?
| | Immunoglobulin alpha-Chains | 1 | 2005 | 1 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2698 | 0.060 |
Why?
| | Hypertrophy | 2 | 2007 | 136 | 0.060 |
Why?
| | Postural Balance | 1 | 2008 | 217 | 0.060 |
Why?
| | Exocytosis | 1 | 2005 | 88 | 0.060 |
Why?
| | Phosphorylation | 3 | 2017 | 1760 | 0.060 |
Why?
| | Evoked Potentials | 3 | 1996 | 129 | 0.060 |
Why?
| | Spectrophotometry | 1 | 2005 | 60 | 0.060 |
Why?
| | Specific Pathogen-Free Organisms | 2 | 2002 | 60 | 0.060 |
Why?
| | RNA | 1 | 2011 | 925 | 0.060 |
Why?
| | Chemokines, CX3C | 1 | 2004 | 10 | 0.060 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 68 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2016 | 1924 | 0.060 |
Why?
| | Progesterone | 1 | 2006 | 258 | 0.050 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2004 | 28 | 0.050 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2004 | 61 | 0.050 |
Why?
| | Down-Regulation | 1 | 2006 | 635 | 0.050 |
Why?
| | Physical Education and Training | 1 | 2024 | 73 | 0.050 |
Why?
| | Antibody Specificity | 1 | 2004 | 187 | 0.050 |
Why?
| | Cholesterol, HDL | 1 | 2005 | 195 | 0.050 |
Why?
| | Concanavalin A | 1 | 2003 | 75 | 0.050 |
Why?
| | Lymphocyte Activation | 2 | 2000 | 1148 | 0.050 |
Why?
| | Blood Pressure | 4 | 2015 | 1739 | 0.050 |
Why?
| | Hypertension | 1 | 2013 | 1242 | 0.050 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 242 | 0.050 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2003 | 18 | 0.050 |
Why?
| | Adult | 10 | 2024 | 38201 | 0.050 |
Why?
| | Immunologic Factors | 1 | 2005 | 243 | 0.050 |
Why?
| | Receptors, Serotonin, 5-HT1 | 1 | 2003 | 8 | 0.050 |
Why?
| | Frontal Lobe | 1 | 2004 | 160 | 0.050 |
Why?
| | Pulmonary Alveoli | 1 | 2006 | 408 | 0.050 |
Why?
| | Leukocytes | 1 | 2005 | 307 | 0.050 |
Why?
| | Receptors, Serotonin | 1 | 2003 | 35 | 0.050 |
Why?
| | Estrogens | 1 | 2006 | 365 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2005 | 394 | 0.050 |
Why?
| | Analgesia | 2 | 1994 | 102 | 0.050 |
Why?
| | Biology | 1 | 2024 | 91 | 0.050 |
Why?
| | Colony-Forming Units Assay | 1 | 2002 | 96 | 0.050 |
Why?
| | Nucleus Accumbens | 2 | 2016 | 148 | 0.050 |
Why?
| | Dermatitis | 1 | 2002 | 19 | 0.050 |
Why?
| | Biomarkers | 3 | 2015 | 4092 | 0.050 |
Why?
| | Cholesterol, LDL | 1 | 2005 | 359 | 0.050 |
Why?
| | Hemoglobins | 1 | 2005 | 357 | 0.050 |
Why?
| | Triglycerides | 1 | 2005 | 513 | 0.050 |
Why?
| | Forecasting | 1 | 2004 | 382 | 0.050 |
Why?
| | Brain Neoplasms | 1 | 1992 | 1267 | 0.050 |
Why?
| | Naloxone | 3 | 2012 | 123 | 0.050 |
Why?
| | Hot Temperature | 2 | 2021 | 393 | 0.050 |
Why?
| | Tissue Distribution | 1 | 2003 | 330 | 0.050 |
Why?
| | Cell Membrane | 1 | 2005 | 716 | 0.050 |
Why?
| | Molecular Chaperones | 1 | 2024 | 196 | 0.050 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2021 | 7 | 0.050 |
Why?
| | Acute Disease | 2 | 2002 | 994 | 0.050 |
Why?
| | Immunologic Memory | 1 | 2004 | 357 | 0.050 |
Why?
| | Cell Division | 1 | 2003 | 794 | 0.050 |
Why?
| | Risk Factors | 1 | 2016 | 10252 | 0.050 |
Why?
| | Reflex, Startle | 2 | 2015 | 69 | 0.050 |
Why?
| | Middle Aged | 4 | 2024 | 33604 | 0.040 |
Why?
| | Epitopes | 1 | 2003 | 475 | 0.040 |
Why?
| | Universities | 1 | 2024 | 434 | 0.040 |
Why?
| | Injections, Intravenous | 2 | 1998 | 202 | 0.040 |
Why?
| | Immunoglobulin Isotypes | 1 | 2001 | 36 | 0.040 |
Why?
| | Learning | 3 | 2008 | 422 | 0.040 |
Why?
| | Mycobacteriaceae | 1 | 2021 | 28 | 0.040 |
Why?
| | Hormone Antagonists | 1 | 2001 | 34 | 0.040 |
Why?
| | Neurons, Afferent | 2 | 1998 | 98 | 0.040 |
Why?
| | Macrophage-1 Antigen | 1 | 2000 | 28 | 0.040 |
Why?
| | Spironolactone | 1 | 2001 | 34 | 0.040 |
Why?
| | Skin | 2 | 2002 | 754 | 0.040 |
Why?
| | Health Status | 1 | 2006 | 819 | 0.040 |
Why?
| | Complement Activation | 1 | 2003 | 403 | 0.040 |
Why?
| | Hypogravity | 1 | 1999 | 4 | 0.040 |
Why?
| | Receptors, Mineralocorticoid | 1 | 1999 | 11 | 0.040 |
Why?
| | Drug Combinations | 1 | 2001 | 346 | 0.040 |
Why?
| | Radiation Injuries, Experimental | 1 | 1999 | 22 | 0.040 |
Why?
| | Phenotype | 2 | 2021 | 3139 | 0.040 |
Why?
| | Obesity | 1 | 1993 | 2962 | 0.040 |
Why?
| | Cells | 1 | 1999 | 25 | 0.040 |
Why?
| | Radiometry | 1 | 1999 | 50 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 1999 | 142 | 0.040 |
Why?
| | Electrophysiology | 2 | 1999 | 217 | 0.040 |
Why?
| | Chronic Disease | 1 | 2006 | 1805 | 0.040 |
Why?
| | Restraint, Physical | 3 | 2010 | 73 | 0.040 |
Why?
| | Social Isolation | 1 | 1999 | 62 | 0.040 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 1999 | 91 | 0.040 |
Why?
| | Erythrocytes | 1 | 2005 | 701 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 728 | 0.040 |
Why?
| | alpha-MSH | 1 | 1998 | 5 | 0.040 |
Why?
| | Endotoxins | 1 | 2000 | 220 | 0.040 |
Why?
| | Eating | 3 | 2000 | 392 | 0.040 |
Why?
| | Peritoneal Cavity | 1 | 1998 | 31 | 0.040 |
Why?
| | United States | 1 | 2016 | 14938 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 336 | 0.040 |
Why?
| | Administration, Oral | 1 | 2001 | 788 | 0.040 |
Why?
| | Mitochondria, Heart | 1 | 1999 | 101 | 0.040 |
Why?
| | Electroencephalography | 1 | 2021 | 444 | 0.040 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 3 | 2007 | 255 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2012 | 2155 | 0.040 |
Why?
| | Staphylococcal Infections | 2 | 2000 | 387 | 0.040 |
Why?
| | Polysomnography | 1 | 2019 | 207 | 0.040 |
Why?
| | Bacteriophages | 1 | 1999 | 98 | 0.040 |
Why?
| | Wakefulness | 1 | 2019 | 138 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2016 | 15909 | 0.040 |
Why?
| | Task Performance and Analysis | 1 | 2019 | 191 | 0.040 |
Why?
| | CD4 Lymphocyte Count | 1 | 1998 | 280 | 0.030 |
Why?
| | Models, Biological | 1 | 2005 | 1806 | 0.030 |
Why?
| | Individuality | 1 | 2019 | 158 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 2923 | 0.030 |
Why?
| | Oxytocics | 1 | 1997 | 15 | 0.030 |
Why?
| | Antigens, CD | 1 | 2000 | 536 | 0.030 |
Why?
| | Models, Molecular | 2 | 2013 | 1587 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 1999 | 333 | 0.030 |
Why?
| | Monitoring, Physiologic | 2 | 2008 | 279 | 0.030 |
Why?
| | Altitude | 1 | 2001 | 467 | 0.030 |
Why?
| | Receptors, Purinergic P2X5 | 1 | 2016 | 4 | 0.030 |
Why?
| | Activating Transcription Factor 3 | 1 | 2016 | 5 | 0.030 |
Why?
| | Dinoprostone | 1 | 1997 | 191 | 0.030 |
Why?
| | Excitatory Amino Acid Transporter 2 | 1 | 2016 | 15 | 0.030 |
Why?
| | p21-Activated Kinases | 1 | 2016 | 13 | 0.030 |
Why?
| | Weight Gain | 1 | 2000 | 532 | 0.030 |
Why?
| | Blotting, Western | 1 | 1999 | 1230 | 0.030 |
Why?
| | Sciatic Neuropathy | 1 | 2016 | 31 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1993 | 3706 | 0.030 |
Why?
| | Orientation | 1 | 1996 | 49 | 0.030 |
Why?
| | Anesthesia | 2 | 1990 | 245 | 0.030 |
Why?
| | Ganglia, Spinal | 1 | 2016 | 85 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 1997 | 215 | 0.030 |
Why?
| | Occupational Exposure | 1 | 1999 | 340 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 1996 | 60 | 0.030 |
Why?
| | Attention | 1 | 2019 | 443 | 0.030 |
Why?
| | Synaptic Transmission | 1 | 1998 | 294 | 0.030 |
Why?
| | Azides | 1 | 1996 | 47 | 0.030 |
Why?
| | Microfilament Proteins | 1 | 2016 | 132 | 0.030 |
Why?
| | Neuroglia | 1 | 2017 | 173 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2016 | 237 | 0.030 |
Why?
| | Functional Laterality | 1 | 2016 | 232 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 280 | 0.030 |
Why?
| | Dopaminergic Neurons | 1 | 2016 | 69 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 155 | 0.030 |
Why?
| | Stem Cells | 1 | 1999 | 599 | 0.030 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 145 | 0.030 |
Why?
| | Spinal Cord | 2 | 2004 | 373 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 215 | 0.030 |
Why?
| | Immobilization | 1 | 2015 | 46 | 0.030 |
Why?
| | Nylons | 1 | 1995 | 20 | 0.030 |
Why?
| | Cytological Techniques | 1 | 1995 | 28 | 0.030 |
Why?
| | Drug Synergism | 2 | 2011 | 368 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2012 | 1262 | 0.030 |
Why?
| | Neck | 1 | 1995 | 104 | 0.030 |
Why?
| | Macrophage Activation | 1 | 1996 | 199 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 453 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4555 | 0.030 |
Why?
| | Cholesterol | 1 | 1996 | 403 | 0.030 |
Why?
| | Melatonin | 1 | 2015 | 154 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 571 | 0.030 |
Why?
| | Memory, Short-Term | 2 | 2008 | 257 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 386 | 0.030 |
Why?
| | Static Electricity | 1 | 2013 | 113 | 0.020 |
Why?
| | CD4-CD8 Ratio | 1 | 1992 | 22 | 0.020 |
Why?
| | Clonidine | 1 | 2013 | 34 | 0.020 |
Why?
| | Amitriptyline | 1 | 2013 | 22 | 0.020 |
Why?
| | Phosphatidylserines | 1 | 2013 | 88 | 0.020 |
Why?
| | Neural Inhibition | 1 | 1994 | 177 | 0.020 |
Why?
| | Myristoylated Alanine-Rich C Kinase Substrate | 1 | 2012 | 6 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2006 | 5803 | 0.020 |
Why?
| | Neurogenesis | 1 | 2014 | 153 | 0.020 |
Why?
| | Unilamellar Liposomes | 1 | 2012 | 8 | 0.020 |
Why?
| | Fasting | 1 | 2014 | 283 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2013 | 167 | 0.020 |
Why?
| | Drug Administration Routes | 1 | 2012 | 41 | 0.020 |
Why?
| | Anthropometry | 1 | 1993 | 208 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2012 | 147 | 0.020 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2012 | 85 | 0.020 |
Why?
| | Pituitary-Adrenal Function Tests | 1 | 2012 | 3 | 0.020 |
Why?
| | Pain Threshold | 1 | 2012 | 75 | 0.020 |
Why?
| | Adolescent Health Services | 1 | 1993 | 76 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2012 | 69 | 0.020 |
Why?
| | Self Administration | 1 | 2012 | 126 | 0.020 |
Why?
| | Hand Strength | 2 | 2004 | 131 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2013 | 193 | 0.020 |
Why?
| | Sex Factors | 2 | 2008 | 2044 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2012 | 105 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 183 | 0.020 |
Why?
| | Sialoglycoproteins | 2 | 2004 | 159 | 0.020 |
Why?
| | Linear Models | 2 | 2004 | 852 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 1992 | 250 | 0.020 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 1992 | 174 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2006 | 10923 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 320 | 0.020 |
Why?
| | Arginine Vasopressin | 1 | 1990 | 43 | 0.020 |
Why?
| | Liposomes | 1 | 2012 | 218 | 0.020 |
Why?
| | Pentobarbital | 1 | 1990 | 18 | 0.020 |
Why?
| | Narcotic Antagonists | 1 | 2012 | 186 | 0.020 |
Why?
| | Urethane | 1 | 1990 | 43 | 0.020 |
Why?
| | Adolescent | 3 | 2004 | 21564 | 0.020 |
Why?
| | Behavior Therapy | 1 | 1993 | 273 | 0.020 |
Why?
| | Vasopressins | 1 | 1990 | 60 | 0.020 |
Why?
| | Risk Assessment | 1 | 1999 | 3433 | 0.020 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2009 | 8 | 0.020 |
Why?
| | Radioimmunoassay | 1 | 2010 | 169 | 0.020 |
Why?
| | Serotonin Receptor Agonists | 1 | 2009 | 26 | 0.020 |
Why?
| | Immunity, Mucosal | 1 | 2011 | 96 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 1992 | 956 | 0.020 |
Why?
| | Serotonin Antagonists | 1 | 2009 | 31 | 0.020 |
Why?
| | Aged, 80 and over | 3 | 2008 | 7677 | 0.020 |
Why?
| | Noise | 1 | 2010 | 64 | 0.020 |
Why?
| | Drinking | 2 | 1999 | 42 | 0.020 |
Why?
| | Bites and Stings | 1 | 1989 | 29 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2011 | 185 | 0.020 |
Why?
| | Program Evaluation | 1 | 1993 | 916 | 0.020 |
Why?
| | Posture | 1 | 1989 | 192 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 471 | 0.020 |
Why?
| | Injections, Intramuscular | 1 | 2008 | 130 | 0.020 |
Why?
| | Amine Oxidase (Copper-Containing) | 1 | 2007 | 5 | 0.020 |
Why?
| | E-Selectin | 1 | 2007 | 56 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 859 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2172 | 0.020 |
Why?
| | Atrophy | 1 | 2007 | 189 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2007 | 142 | 0.020 |
Why?
| | Nanoparticles | 1 | 2012 | 469 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2006 | 71 | 0.020 |
Why?
| | Action Potentials | 3 | 1999 | 485 | 0.020 |
Why?
| | Epithelial Sodium Channels | 1 | 2006 | 21 | 0.020 |
Why?
| | Protein Binding | 1 | 2012 | 2225 | 0.020 |
Why?
| | Cell Line | 1 | 1992 | 2876 | 0.020 |
Why?
| | Sodium Channels | 1 | 2006 | 62 | 0.020 |
Why?
| | Models, Animal | 1 | 2007 | 395 | 0.010 |
Why?
| | Epithelium | 1 | 2006 | 316 | 0.010 |
Why?
| | Autoimmunity | 1 | 1991 | 903 | 0.010 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2004 | 19 | 0.010 |
Why?
| | Receptors, HIV | 1 | 2004 | 25 | 0.010 |
Why?
| | Chemokine CX3CL1 | 1 | 2004 | 25 | 0.010 |
Why?
| | Receptors, Cytokine | 1 | 2004 | 36 | 0.010 |
Why?
| | Bronchi | 1 | 2006 | 269 | 0.010 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2004 | 29 | 0.010 |
Why?
| | Injections, Spinal | 1 | 2004 | 108 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1092 | 0.010 |
Why?
| | Drug Tolerance | 1 | 2004 | 105 | 0.010 |
Why?
| | Drug Implants | 2 | 1996 | 83 | 0.010 |
Why?
| | Complement C4a | 1 | 2003 | 8 | 0.010 |
Why?
| | Hormones | 1 | 2004 | 140 | 0.010 |
Why?
| | Social Environment | 2 | 1996 | 295 | 0.010 |
Why?
| | Catheterization | 1 | 2004 | 181 | 0.010 |
Why?
| | Histamine | 1 | 2003 | 59 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 2003 | 167 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2004 | 810 | 0.010 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2004 | 196 | 0.010 |
Why?
| | Isometric Contraction | 1 | 2004 | 179 | 0.010 |
Why?
| | Genetic Therapy | 1 | 2004 | 314 | 0.010 |
Why?
| | Electromyography | 1 | 2004 | 401 | 0.010 |
Why?
| | Adrenergic alpha-Agonists | 1 | 2001 | 28 | 0.010 |
Why?
| | Anaerobic Threshold | 1 | 2001 | 28 | 0.010 |
Why?
| | Mental Status Schedule | 1 | 2001 | 34 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2004 | 431 | 0.010 |
Why?
| | Cholecystokinin | 1 | 2000 | 15 | 0.010 |
Why?
| | Mathematics | 1 | 2001 | 101 | 0.010 |
Why?
| | Menstrual Cycle | 1 | 2001 | 133 | 0.010 |
Why?
| | Pain Management | 1 | 2004 | 389 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2000 | 83 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 2000 | 199 | 0.010 |
Why?
| | Dimerization | 1 | 2000 | 196 | 0.010 |
Why?
| | Listeriosis | 1 | 2000 | 69 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 166 | 0.010 |
Why?
| | Allergens | 1 | 2003 | 400 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2006 | 922 | 0.010 |
Why?
| | Ovary | 1 | 2001 | 223 | 0.010 |
Why?
| | Therapeutic Irrigation | 1 | 2000 | 79 | 0.010 |
Why?
| | Cerebellum | 1 | 2000 | 218 | 0.010 |
Why?
| | Glossopharyngeal Nerve | 1 | 1998 | 11 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2008 | 5112 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2001 | 710 | 0.010 |
Why?
| | Afferent Pathways | 1 | 1998 | 47 | 0.010 |
Why?
| | Rats, Long-Evans | 1 | 1998 | 122 | 0.010 |
Why?
| | Young Adult | 1 | 2015 | 13305 | 0.010 |
Why?
| | Nodose Ganglion | 1 | 1997 | 5 | 0.010 |
Why?
| | Cerebral Cortex | 1 | 2000 | 452 | 0.010 |
Why?
| | Amnesia, Retrograde | 1 | 1996 | 3 | 0.010 |
Why?
| | Appetitive Behavior | 1 | 1996 | 8 | 0.010 |
Why?
| | Sodium Azide | 1 | 1996 | 6 | 0.010 |
Why?
| | Synaptic Membranes | 1 | 1996 | 16 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1996 | 43 | 0.010 |
Why?
| | Zymosan | 1 | 1996 | 66 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2003 | 3523 | 0.010 |
Why?
| | Neoplasms | 1 | 2011 | 2681 | 0.010 |
Why?
| | Space Perception | 1 | 1996 | 81 | 0.010 |
Why?
| | Chlorisondamine | 1 | 1994 | 3 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 9 | 0.010 |
Why?
| | Child | 1 | 1993 | 21921 | 0.010 |
Why?
| | Skin Temperature | 1 | 1993 | 30 | 0.010 |
Why?
| | Binding Sites | 1 | 1996 | 1313 | 0.010 |
Why?
| | Pyramidal Tracts | 1 | 1992 | 31 | 0.010 |
Why?
| | Cold Temperature | 1 | 1993 | 188 | 0.010 |
Why?
| | Regression Analysis | 1 | 1992 | 1017 | 0.000 |
Why?
| | Mitochondria | 1 | 1996 | 955 | 0.000 |
Why?
| | Immunoglobulin gamma-Chains | 1 | 1988 | 2 | 0.000 |
Why?
|
|
Fleshner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|